Necl-5/Poliovirus Receptor Interacts in cis with Integrin αVβ3 and Regulates Its Clustering and Focal Complex Formation

Integrin α v β 3 , which forms focal complexes at leading edges in moving cells, is up-regulated in cancer cells and so is implicated in their invasiveness. Necl-5, originally identified as a poliovirus receptor and also up-regulated in cancer cells, colocalizes with integrin α v β 3 at leading...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of biological chemistry 2007-06, Vol.282 (25), p.18481
Hauptverfasser: Yukiko Minami, Wataru Ikeda, Mihoko Kajita, Tsutomu Fujito, Hisayuki Amano, Yoshiyuki Tamaru, Kaori Kuramitsu, Yasuhisa Sakamoto, Morito Monden, Yoshimi Takai
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Integrin α v β 3 , which forms focal complexes at leading edges in moving cells, is up-regulated in cancer cells and so is implicated in their invasiveness. Necl-5, originally identified as a poliovirus receptor and also up-regulated in cancer cells, colocalizes with integrin α v β 3 at leading edges in moving cells and enhances growth factor-induced cell movement. Here, we show that Necl-5 interacts directly, in cis , with integrin α v β 3 , and enhances integrin α v β 3 clustering and focal complex formation at leading edges in NIH3T3 cells. The extracellular region of Necl-5, but not the cytoplasmic region, is necessary for its interaction with integrin α v β 3 ; however, both regions are necessary for its action. An interaction between integrin α v β 3 and vitronectin and PDGF-induced activation of Rac are also necessary for integrin α v β 3 clustering. The interaction between Necl-5 and integrin α v β 3 enhances PDGF-induced Rac activation, facilitating integrin α v β 3 clustering presumably in a feedback amplification manner. Thus, Necl-5 has a critical role in integrin α v β 3 clustering and focal complex formation.
ISSN:0021-9258
1083-351X
DOI:10.1074/jbc.M611330200